Bart Crielaard
Bart Crielaard
Assistant Professor, Zernike Institute for Advanced Materials, University of Groningen
Geverifieerd e-mailadres voor rug.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
P Ramos, C Casu, S Gardenghi, L Breda, BJ Crielaard, E Guy, ...
Nature medicine 19 (4), 437, 2013
1802013
Targeting iron metabolism in drug discovery and delivery
BJ Crielaard, T Lammers, S Rivella
Nature Reviews Drug Discovery 16 (6), 400, 2017
1242017
Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes
L Quan, Y Zhang, BJ Crielaard, A Dusad, SM Lele, CJF Rijcken, ...
ACS nano 8 (1), 458-466, 2014
942014
Glucocorticoid‐loaded core‐cross‐linked polymeric micelles with tailorable release kinetics for targeted therapy of rheumatoid arthritis
BJ Crielaard, CJF Rijcken, L Quan, S Van Der Wal, I Altintas, ...
Angewandte Chemie 124 (29), 7366-7370, 2012
922012
Drug targeting systems for inflammatory disease: one for all, all for one
BJ Crielaard, T Lammers, RM Schiffelers, G Storm
Journal of controlled release 161 (2), 225-234, 2012
842012
Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus
S Gardenghi, TM Renaud, A Meloni, C Casu, BJ Crielaard, LM Bystrom, ...
Blood 123 (8), 1137-1145, 2014
732014
A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis
D Neut, OS Kluin, BJ Crielaard, HC van der Mei, HJ Busscher, ...
Acta orthopaedica 80 (5), 514-519, 2009
582009
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer
B Ozbakir, BJ Crielaard, JM Metselaar, G Storm, T Lammers
Journal of controlled release 190, 624-636, 2014
562014
Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model
F Leonard, H Ali, EM Collnot, BJ Crielaard, T Lammers, G Storm, CM Lehr
ALTEX-Alternatives to animal experimentation 29 (3), 275-285, 2012
522012
Macrophages and liposomes in inflammatory disease: friends or foes?
BJ Crielaard, T Lammers, ME Morgan, L Chaabane, S Carboni, B Greco, ...
International journal of pharmaceutics 416 (2), 499-506, 2011
422011
Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles
P Vader, BJ Crielaard, SM Van Dommelen, R Van der Meel, G Storm, ...
Journal of controlled release 160 (2), 211-216, 2012
352012
MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate
E Cittadino, M Ferraretto, E Torres, A Maiocchi, BJ Crielaard, T Lammers, ...
European journal of pharmaceutical sciences 45 (4), 436-441, 2012
332012
An in vitro assay based on surface plasmon resonance to predict the in vivo circulation kinetics of liposomes
BJ Crielaard, A Yousefi, JP Schillemans, C Vermehren, K Buyens, ...
Journal of controlled release 156 (3), 307-314, 2011
322011
Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics
BJ Crielaard, S van der Wal, HT Le, ATL Bode, T Lammers, WE Hennink, ...
European journal of pharmaceutical sciences 45 (4), 429-435, 2012
312012
Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate‐containing liposomes improves neurological outcome and restricts lesion progression …
IACW Tiebosch, BJ Crielaard, MJRJ Bouts, R Zwartbol, A Salas‐Perdomo, ...
Journal of neurochemistry 123, 65-74, 2012
252012
A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
BJ Crielaard, S Van Der Wal, T Lammers, HT Le, WE Hennink, ...
International journal of nanomedicine 6, 2697, 2011
252011
Efficient Fusion of Liposomes by Nucleobase Quadruple‐Anchored DNA
Z Meng, J Yang, Q Liu, JW de Vries, A Gruszka, A Rodríguez‐Pulido, ...
Chemistry–A European Journal 23 (39), 9391-9396, 2017
212017
Critical factors in the development of tumor-targeted anti-inflammatory nanomedicines
M Coimbra, BJ Crielaard, G Storm, RM Schiffelers
Journal of controlled release 160 (2), 232-238, 2012
162012
β-Thalassemia and Polycythemia vera: Targeting chronic stress erythropoiesis
BJ Crielaard, S Rivella
The international journal of biochemistry & cell biology 51, 89-92, 2014
152014
Polycythemia is associated with bone loss and reduced osteoblast activity in mice
PR Oikonomidou, C Casu, Z Yang, B Crielaard, JH Shim, S Rivella, ...
Osteoporosis International 27 (4), 1559-1568, 2016
112016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20